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1059-l 35 Coronary Bypass Grafts: Assessment of Crltlcal 
3-O Anatomlc Featuws 
C0fQttGfy ~ft~flOQmphy y&k3 2.8 pfQ~@CllQll lIlM@S Ot @+YSS (IrstIS. Ad- 
vances rn fnkxventlonal (hcmpy requrre rncreasmgly complex, quanfttative 
mlarmation ospec~al)y in the era of @tent depfoyment. To quanllty these param- 
eCw we Wred 3-R recandructwn tgchnrques lhat only requrra ~WQ rrtandttrd 
anglegraph~ crews of the v@%ef te be fecoftstfucled. A lotal at ZJ graft@ w@ro 
rcw4wwctett anb wal graft Cngfh a~4 0egrw of wwot41ty (Ihe avem~ taw 
~ntang~rela~teaatr?~htL~ailB~nttlravttladOwnltrgg~H~~ndemre~. 
ReNra: Sacdwwa vem grafta (SVG) were 11.2 t 3.5 cm m bngfh lor 
all focatrons; W/G-LAP were @~ffost (n = 8- 8.4 t 1.9 cm) and SVGzRtZA (n 
= It. 12.2 2 2.5 cm) and SVG-Qm (n = 13: 12.1 t 4.4 cm) were fonger (p 
. 0.005). In wvo accuracy sf~W usmg a PTCA wtfe with 15 mm markers 
showed a2%onw tnfongthmeaeurement by 3W1.a. 2 mmma tOcmgraft). 
Tortuorxty averaged 34 f 10 deqmes tof all SVG. S/G&AD berng least (29 
1 9 dogreen) and SVG:RCA the it fortuous (42 t 6 degrees. p .‘ 0.005) 
Inlemal mammary grafts (n = 4) were even longer and more lortuous 
Con&us-: 3-D recamitrwztron of bypass gratis y+.?lc@ Important pawnt- 
emfic mfvrrnabon (length, tortuority. aml vrewa that mmtmlze Ioreahorten- 
mg) which assist m developing an mferventmnal strategy Unkke rntravascular 
~nmsotmd. no groan rrrsfrumerrta0on IS necessary wrth this technrque 
1059-l 36 Post-revasculari$aHon Cornnary Disease and 
nrst Year outcoms 
4 S. Kurbaan. T.J. Rowker. A.F. Rrckards Cb? behaff al Me CABI?/ 
~~Iw?s~@oR% fbpl8mmplon noSprfai (ICSnMi. LOIXWI. UK 
The extent to whrch post-revasc~tiarrsatron coronary hsease contributes to 
an unfavorable outcome rs uncedam. The assocrahon between the extent ot 
post-revascutansahon coronary drsease an5 hrst year outcome in a mafor 
revascufansdlron tnal (CABRI) was assessed. 
ALlho& A number of measures of post-revasculansatr coronary dis- 
ease were utikzed rn the CABRI populatron. These measures were both 
werghted for proxtmaf drsease (Duke and Learnan) and non-we@ted They 
were men cuss-tabulated against the frrst year outcomes 01 mortakty. non- 
penprocedura~ myocardral mtarcbon. repeat revascutansahon and angma 
ccsgrade 21 
Resu~r Ustng any ot the measures of post-reva%XlanSatrOn coronary 
dtsease there was no assoczatron between resrduat dfsease and death or 
non-penprocedural myocardral mtarctron. However. vvlth the Duke measure 
the presemx 01 post-w.ascularrsaiion coronary drsease was assocrarcd 
&clrth a relattve nsk (RR) of repeat revasculansahon ot 2 0 (95’. Confidence 
Interval 1.52-2.63) and relative nsk of angma CCS grade ,I 1 011 86 195% Cl 
1 32-2 64) Usmg the Leaman measure the respectwe values were RR = 1 97 
;95”- Cl 1.47-Z 59) tor repeat revasculansatmn and RR = 1.88 (1 33-2 66) 
for angma CCS > 1. 
CorrcIus~on: In the first year analysrs of the CABRI populatton snows 
that post-revasculansatton coronary disease was associated wrth both a 
greater need for repeat revasculansatron and a poorer angma status. but not 
death or myocardral mfarctron The assocratron was strOt’tgeS1 \mth proximal 
post-revasculansatron coronary disease. 
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Treatment 
Monday, March 30. 1998,3:00 p.m.-5:OO p.m. 
Georgia World Congress Center. West Exhibit Hall Level 
Presentation Hour: 3:00 p.m.400 p.m. 
I .* 1060-77 Influence of Routine Angiographic Follow-up on Chntcal f&stenosis Outcome in the ASCENT Trial 
IX. Cutlrp. K.K.L. Ho, RI. Kuntz. D S. Balm. Befh lsrael Deacvness 
Medical Center. Bostoon. !&I. USA 
ASCENT IS a randomized tnal comparing the ACS MULTI-LINK (ML) stem to 
the Palmaz-Schatz (PS) stent for the primary endpolnt of clmical target vessel 
failure. defmed asdealh. MI. or target vessel revascularization (TVR). While tt 
IS generally believed that lVR is independent of late angiography. ASCENT 
assigned 538 patients lo routine 9 month angiographic Illow-up (A), and 
the remainmg 502 patients (C) to clinical follow-up (repeat angiogmphy 
recommended only for recurrent angina or functional evidence of ischemia). 
The influence of routine angiographic follow-up on TVR (Table). is broken 
down by A vs. C lollow.~p and by those with (I+) and wlthout (I-) Clinical 
evrdence of ischemla. 
II 1060~98 Effects ot ClhxNazol on Rostenorir Aftw Palm~SchrtX Corwwy Sosnl lmpfanlclkn 
K Kozuma. K Hara. Y. fvlormo. H. Maekewa, S Ayabe, H Ushrktlrilk. 
Y Kuroda. F. Saekl. f. Tamura Drvrscon of Cardiology, h4&eur i$&morrat 
&WlW ro&o. &pan 
Back_@round C~lostazol mhlbtts mltmal hyperplasia atter 5tenf rmplantafron in 
canme ilrac artsnes 
Methods: To delermme whether ihta agent prevents angmgraphrc reste- 
noms after etent Implantation. we randomly gave cilostazol (ZOO mgidayj 
or trclopfdme (ZOO mgday) at feast for 3 months after tf~ Palmar.Schatz 
stem rmplantabon in 69 patrente. Complete angrographjc data have baen 
obtamed m 76 petreflts. Mrmmal lummal diameters were delermmad by an 
~tectron metnod at baselme (pm MLD), alter mterventron (past MLD), 
and at &monfh fofIowvp (fu MLD) 
Rest&: One patrent tereated wWr I~lopfdtne had subacute thmmbasts. 
but rmrle wltfl cllO6tazOI 
WWl%SD) CIIWI TKlOQ&IW P 
No OIlFStcN 41 54 
rerennce ,mm, 29Q0rOBl 3lOr0.44 
pre MLD (mm) 078tO44 098 r036 0”; 
wslMlD lmml 228rOz.7 238x039 “6 
rsar046 tMX051 003 
D40:03R 0 74 5 0 58 .0905 
6033 l”de. 027rOlO 05, r014 -0005 
resle”o91cx rate 19% 33% “5 
Conc/wons. These results suggest that c81ostazoI may be efiectlve to 
prevent restenosrs after stent fmplamatron 
i 1060-79 / Risk Factor Analysis for the Dsvalopment of 
Restenosis After lntracoronary B?nl tmplantmion 
With Adjunct High Pressure Stent Dil5tatlon 
M. HaucYf?. G Caspan. 0 Baumgart. D We&. F LIU. A Erbel, Cardrulogy 
&parfmel7f. Cenfer of hferrfaf MedKx?e. ufvversfTyy/GHs Essen. Germany 
Atm ot this stucty was to detect the mlpacl 01 hrgh pressure stent dllatatron 
(HPSD) on Ihe development of sfent restenosts and lo dehne nsk factors. 
Gmup 1 constituted of 130 pahents (pts). In whom 166 Palmaz %hatZ (PS) 
stems were m@anted wrthcut HPSD For comparison.. group 2 consl~ruted 
of 150 pts m whom 249 PS stents were tmplanfed wrth HPSD (~16 sfm) 
Lnrvanate nsk hctor analrjrs was performed by calNlalrOn of odds rabos 
and 95% confrderrce tntervals. Stepwrse logisfrc regression analysts was 
used to dehne mdepcndent nsk factors. Bolh groups were comparable wth 
respect to thetr baseline parameters. except that tn group 2 longer IeSlOnS 
(9.9 : 2 2 mm versu3 7 6 t 1 6 mm. p - 0 001) were treated m larger v@ssefs 
(3.12 f 0.43 mm versus 3.02 x 0 40 mm; p . 0 01) Resrencsrs rJte t .50% 
drameter steno% at follow-up) was 24% ln gmup 1 and 16% In group 2 
Out of 52 anamnestrc. procedural and anglographlc parameters the foffdvlng 
were rdenIWl as nsk factors 
Group 1 
relative risk 
